通过激活p53来增强调控性T细胞依赖的免疫耐受性
Xiaopei Cui1, Chun-Guang Li2, Haiqing Gao1
1Shandong Key Laboratory of Cardiovascular Proteomics and Department of Geriatric Medicine, Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province, China.
International immunopharmacology
|November 6, 2023
概括
作为p53激活剂的CX-5461,通过促进调控性T细胞 (Treg) 分化,显示出作为免疫抑制剂的潜力. 这种独特的机制为免疫耐受性和预防移植排斥提供了一种新的方法.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 调节性T细胞 (Tregs) 对免疫平衡至关重要,并具有抗炎性质.
- 传统的免疫抑制剂在控制免疫反应方面存在局限性.
- CX-5461是一种选择性RNA聚合酶I抑制剂和p53激活剂,具有以前未知的免疫抑制能力.
研究的目的:
- 探索CX-5461的新型免疫抑制机制.
- 研究p53在促进调控性T细胞 (Treg) 分化中的作用.
- 评估p53激活剂在增强免疫耐受性方面的潜力.
主要方法:
- 对p53和Treg分化的现有证据的审查.
- 对涉及FoxP3,PTEN和STAT5.5的潜在分子机制的分析.
- 在动物模型中评估CX-5461对全原性急性排斥的影响.
主要成果:
- CX-5461表现出强大的免疫抑制作用,防止异构性急性排斥.
- 发现CX-5461通过与传统药物不同的机制促进Treg分化.
- 有证据表明,p53通过FoxP3转录,PTEN表达和STAT5相互作用来调节Treg分化.
结论:
- 药理上的p53激活可能会增强Treg介导的免疫耐受性.
- 像CX-5461这样的新型p53激活剂代表了一类新的免疫抑制剂.
- 这些药物可能会抑制T细胞介导的免疫,同时提高Treg-依赖的耐受性.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Tumor Immunotherapy
533
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
533


